Abstract 5442: <i>In vitro</i> and <i>in vivo</i> upregulation of thymidine phosphorylase expression in colon cancer cells by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with capecitabine

Elena Di Gennaro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alfredo Budillon(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Claudio Arra(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Tania Moccia(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Geny Piro(University of Verona), Antonio Luciano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Chianese(University of Trieste), Francesca Bruzzese(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessandra Di Cintio(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cancer Research
April 1, 2010
10.1158/1538-7445.am10-5442
Cited by 0

Related Papers

Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
|Journal of Experimental & Clinical Cancer Research|2019|125
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
|Pharmaceuticals|2024|86
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
|Cell Death and Disease|2013|63
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
|Cell Death and Disease|2013|57